An Open-label, Multi-center Phase Ib/II Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Latest Information Update: 05 Oct 2023
At a glance
- Drugs Cytarabine (Primary) ; Mitoxantrone liposomal (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 08 Nov 2021 New trial record